Story perspectives

Health Secretary Calls for Caution in Puberty Blockers Trial

12/13/2025

Summary

Story summary

Health Secretary Wes Streeting expressed discomfort with a puberty blockers trial for children and urged cross-party consensus on gender identity services.
The trial involves over 200 children and follows the Cass Review, which found weak evidence for puberty blockers.
Critics, including Conservative leader Kemi Badenoch, warn the trial risks vulnerable children.
Streeting says the trial is essential for evidence-based decisions on treatment pathways for gender incongruence.

1 of 1

Story summary

Health Secretary Wes Streeting expressed discomfort with a puberty blockers trial for children and urged cross-party consensus on gender identity services.
The trial involves over 200 children and follows the Cass Review, which found weak evidence for puberty blockers.
Critics, including Conservative leader Kemi Badenoch, warn the trial risks vulnerable children.
Streeting says the trial is essential for evidence-based decisions on treatment pathways for gender incongruence.